GLP1R and cancer: Similarly to our study, the comparable effect of BMS and GLP1-RA on cancer risk in individuals with BMI≥35 kg/m2 (not necessarily living with diabetes) was presented in a head-to-head comparison of ∼20 k propensity-score-matched pairs, based on data from TriNetX, a global healthcare database.